COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
−2.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 21.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.11x
- Price / sales
- 11.38x
- Price / cash flow
- -0.01x
Enterprise value
- Enterprise value
- $48.1M
- EV / sales
- 5.99x
- EV / EBITDA
- -2.18x
- EV / EBIT
- -2.12x
- Market cap
- $91.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026